Growth Metrics

Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026)

Cardiol Therapeutics filings provide 3 years of Other Working Capital Changes readings, the most recent being $210370.7 for Q4 2022.

  • On a quarterly basis, Other Working Capital Changes rose 128.46% to $210370.7 in Q4 2022 year-over-year; TTM through Dec 2022 was $1.0 million, a 159.7% increase, with the full-year FY2025 number at -$810520.2, down 616.3% from a year prior.
  • Other Working Capital Changes hit $210370.7 in Q4 2022 for Cardiol Therapeutics, down from $757584.4 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $757584.4 in Q3 2022 to a low of -$935642.5 in Q1 2021.
  • Median Other Working Capital Changes over the past 3 years was $210370.7 (2022), compared with a mean of -$47022.7.
  • Biggest five-year swings in Other Working Capital Changes: crashed 377.04% in 2021 and later surged 196.74% in 2022.
  • Cardiol Therapeutics' Other Working Capital Changes stood at $266787.7 in 2020, then crashed by 377.04% to -$739100.5 in 2021, then skyrocketed by 128.46% to $210370.7 in 2022.
  • The last three reported values for Other Working Capital Changes were $210370.7 (Q4 2022), $757584.4 (Q3 2022), and $504615.8 (Q2 2022) per Business Quant data.